SLC5A2 and diabetic kidney disease: Furthermore, some studies have reported the mechanisms through which SGLT2 inhibitors regulate PCD for kidney protection in DKD.SIRT1/AMPK were activated by SGLT2 inhibitors, and Akt/mTOR signaling is inhibited at the same time, which regulate autophagy (136).